Deprecated: Creation of dynamic property Responsive_Lightbox_Lite::$choices is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/responsive-lightbox-lite/responsive-lightbox-lite.php on line 470

Deprecated: Creation of dynamic property Responsive_Lightbox_Lite::$loading_places is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/responsive-lightbox-lite/responsive-lightbox-lite.php on line 475
Stock market announcements Archive - Page 9 of 24 - Lifecare
Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Stock market announcement archive

LIFE: Lifecare secures funding to establish automated production and further product development.

October 20, 2023
Bergen, Norway, October 20th, 2023: Lifecare AS (LIFE) (the "Company"), aclinical stage medical sensor company developing the next generation ContinuousGlucose Monitor (CGM), has successfully completed a capital increase of NOK42,500,000 in a private placement. The equity raised ensures Lifecare's financing needs to establish automatedproduction, as well as further product development. The company's statedobjective is to […]
Read more

Lifecare – Successful completion of private placement

October 19, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the announcement published on 19 October 2023 by LifecareAS […]
Read more

Lifecare – Contemplated private placement

October 19, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Lifecare AS ("Lifecare" or the "Company") has retained Carnegie AS as bookrunnerand manager […]
Read more

LIFE: Confirmation from Norwegian Medicines Agency

October 17, 2023
Bergen, Norway, October 17th, 2023: Today, Lifecare AS (LIFE), a clinical stagemedical sensor company developing the next generation Continuous Glucose Monitor(CGM), can reveal an important announcement about regulatory confirmation fromNorwegian Medicines Agency (Statens Legemiddelverk).In the process of Lifecare's initial planning and preparations to bring SencellCGM to the veterinary market, Lifecare Veterinary has asked for regulatoryclarifications […]
Read more

Lifecare – Progress as planned towards ISO 13485 compliance

October 12, 2023
Bergen, Norway, October 12th, 2023: Today, Lifecare AS (LIFE), a clinical stagemedical sensor company developing the next generation Continuous Glucose Monitor(CGM), can disclose that Lifecare Laboratory (Mainz, Germany) is consideredready for ISO 13485 audit.ISO 13485 is a Quality Management System specific to medical devices and coversthe entire life cycle of a device, from design and […]
Read more

LIFE: Lifecare- Purchase software for automated production

October 2, 2023
Bergen, Norway, October 2nd, 2023: Lifecare AS (LIFE), a clinical stage medicalsensor company developing the next generation Continuous Glucose Monitor (CGM))has now placed the purchase order for automated production software. Reference is made to Lifecare's list of trigger events, as presented at thesemi-annual report of August 20th 2023 and later investor communication. Thelaunch of an […]
Read more

LIFE: Lifecare to present company update at Redeye Medtech & Diagnostics Seminar today

September 26, 2023
Bergen, Norway, September 22, 2023: Lifecare AS (LIFE), a clinical stage medicalsensor company developing the next generation Continuous Glucose Monitor (CGM)will participate at Redeye Medtech & Diagnostics Seminar. On 26 September at 1310 Lifecare will present latest developments from thecompany at the Redeye Medtech & Diagnostics Seminar. The presentation deck isenclosed. The presentation is live […]
Read more

LIFE: Lifecare announces presentation of additional clinical data from study LFS-SEN-001

September 22, 2023
Bergen, Norway, September 22, 2023: Lifecare AS (LIFE), a clinical stage medicalsensor company developing the next generation Continuous Glucose Monitor (CGM)announce today that additional clinical data from study LFS-SEN-001 will bepresented at the upcoming international diabetes conference hosted by theDiabetes Technology Society. Lifecare CSO, Professor Dr. Dr. Med. Andreas Pfützner has received an invitationto present […]
Read more

Lifecare – Sanofi Product Development Agreement Update

September 19, 2023
Reference is made to previous investor communication, i.e. September 23, 2021and later. Lifecare is engaged with Sanofi in a Product Development Agreementaimed at advancing the miniaturization of Lifecare's sensor technology forintegration into Lifecare's Sencell Continuous Glucose Monitoring system.Under the terms of the agreement, Sanofi has committed to provide fundingcontributions, supporting the further development of Lifecare's […]
Read more

LIFE: Towards market readiness

August 23, 2023
Lifecare has shown major progress in our plan to bring the smallest ContinuousGlucose Monitor (CGM) system to the market. Testing in live tissue,implementation of Quality Management System and set up of manufacturingcapabilities form the three main pillars in our market-oriented development. - The results from studies concluded in 1H 2023 and the status of the […]
Read more